Related Experiment Video
Updated: May 1, 2026

Bioassays for Monitoring Insecticide Resistance
Published on: December 30, 2010
Genetic analysis of chlorantraniliprole resistance in the non-target bio-control agent Trichogrammachilonis
Muhammad Kamran1, Muhammad Ahmad1, Sarfraz Ali Shad1
1Department of Entomology, Faculty of Agricultural Sciences and Technology, Bahauddin Zakariya University, Multan, 60800, Pakistan.
Abstract:
Trichogramma chilonis (Ishii) (Hymenoptera: Trichogrammatidae), a widely used egg parasitoid of lepidopteran pests in various crops, has developed very high levels of resistance when treated with chlorantraniliprole under laboratory conditions. This study assessed and characterized its mode of inheritance, degree of dominance, realized heritability (h2), and cross-resistance. Toxicity bioassays were performed on T. chilonis adults using a dry film residue method. The chlorantraniliprole resistant strain (Chlr-R) of T. chilonis showed >25000-fold resistance as compared with chlorantraniliprole susceptible strain (Chlr-S). The chlorantraniliprole resistance in T. chilonis was characterized as incompletely dominant and governed by multiple autosomal genes. Additionally, the resistance of T. chilonis to chlorantraniliprole shifted from functionally dominant (at lower applied doses) to functionally recessive (at highest applied dose). Parameters regarding the h2 of chlorantraniliprole resistance in T. chilonis predicted 10-fold rise in the initial LC50 after 14.28 generations with continuous selections (at h2 = 0.24). No obvious cross-resistance to cypermethrin and chlorpyrifos and a very low cross-resistance to flonicamid were detected. These findings are helpful to improve the field-based effectiveness and integration of these wasps with chemical control.
More Related Videos
08:53Application of Two-spotted Spider Mite Tetranychus urticae for Plant-pest Interaction Studies
Published on: July 4, 2014
05:29Author Spotlight: Investigating Wolbachia-Induced Thelytokous Parthenogenesis and Genetic Toolkit Development Through RNA Interference
Published on: November 21, 2023
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets